Ftse Mib
33.885,98
0,76%
DAX
18.139,26
0,81%
S&P 500
5.157,40
0,58%
NASDAQ
16.200,69
0,27%
Bitcoin
63.939,76
-0,09%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Alder BioPharmaceuticals Inc (ALDR) Alder BioPharmaceuticals Inc (ALDR) Notizie

ALDR

Alder BioPharmaceuticals (ALDR)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ALDR
DataOraFonteTitoloSimboloCompagnia
13/02/202022:19Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ALDRAlder BioPharmaceuticals Inc
01/11/201916:45Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:ALDRAlder BioPharmaceuticals Inc
31/10/201921:28Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ALDRAlder BioPharmaceuticals Inc
25/10/201912:10Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ALDRAlder BioPharmaceuticals Inc
25/10/201901:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALDRAlder BioPharmaceuticals Inc
22/10/201923:33Edgar (US Regulatory)Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)NASDAQ:ALDRAlder BioPharmaceuticals Inc
22/10/201923:13Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ALDRAlder BioPharmaceuticals Inc
22/10/201915:26Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:ALDRAlder BioPharmaceuticals Inc
22/10/201915:15Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:ALDRAlder BioPharmaceuticals Inc
22/10/201915:04Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:ALDRAlder BioPharmaceuticals Inc
22/10/201915:04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ALDRAlder BioPharmaceuticals Inc
11/10/201914:00GlobeNewswire Inc.Lundbeck and Alder BioPharmaceuticals announce updated information in the tender offer materials filed with SECNASDAQ:ALDRAlder BioPharmaceuticals Inc
10/10/201918:12Edgar (US Regulatory)Schedule 13gNASDAQ:ALDRAlder BioPharmaceuticals Inc
10/10/201914:01GlobeNewswire Inc.Alder BioPharmaceuticals® Announces First-in-Human Dosing in Phase 1 ALD1910 Study for Preventive Treatment of MigraineNASDAQ:ALDRAlder BioPharmaceuticals Inc
26/09/201920:18Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ALDRAlder BioPharmaceuticals Inc
26/09/201919:26Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:ALDRAlder BioPharmaceuticals Inc
23/09/201922:08Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:ALDRAlder BioPharmaceuticals Inc
23/09/201921:25Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:ALDRAlder BioPharmaceuticals Inc
18/09/201922:51Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:ALDRAlder BioPharmaceuticals Inc
18/09/201900:14PR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Alder Biopharmaceuticals, Inc.NASDAQ:ALDRAlder BioPharmaceuticals Inc
16/09/201923:15Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:ALDRAlder BioPharmaceuticals Inc
16/09/201917:09PR Newswire (US)Shareholder Alert: Ademi & O'Reilly, LLP Investigates whether Alder BioPharmaceuticals has obtained a Fair Price in its sale ...NASDAQ:ALDRAlder BioPharmaceuticals Inc
16/09/201913:46PR Newswire (US)Alder (ALDR) Alert: Johnson Fistel Investigates Proposed Sale of Alder BioPharmaceuticals, Inc.; Are Shareholders Getting a F...NASDAQ:ALDRAlder BioPharmaceuticals Inc
05/09/201922:01GlobeNewswire Inc.Alder BioPharmaceuticals® to Showcase Data from Migraine Prevention Portfolio at 19th Congress of the International Headache...NASDAQ:ALDRAlder BioPharmaceuticals Inc
04/09/201915:00PR Newswire (US)Bolt Biotherapeutics Appoints Veteran Executive Randall Schatzman as CEO to Lead the Next Phase of GrowthNASDAQ:ALDRAlder BioPharmaceuticals Inc
30/08/201922:01GlobeNewswire Inc.Alder BioPharmaceuticals® Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ALDRAlder BioPharmaceuticals Inc
28/08/201922:01GlobeNewswire Inc.Alder BioPharmaceuticals® to Present at Two Upcoming September Investor ConferencesNASDAQ:ALDRAlder BioPharmaceuticals Inc
06/08/201922:07GlobeNewswire Inc.Alder BioPharmaceuticals® Reports Second Quarter 2019 Financial and Operating ResultsNASDAQ:ALDRAlder BioPharmaceuticals Inc
06/08/201922:03Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ALDRAlder BioPharmaceuticals Inc
02/08/201922:01GlobeNewswire Inc.Alder BioPharmaceuticals® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ALDRAlder BioPharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ALDR

La tua Cronologia

BIT
ISP
Intesa Sanpaolo
BIT
UCG
Unicredit
BIT
ENEL
Enel
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
STLAM
Stellantis NV
BIT
AMP
Amplifon
BIT
RACE
Ferrari NV
BIT
ENI
Eni
BIT
BPE
Bper Banca
BIT
LDO
Leonardo
BIT
BAMI
Banco BPM
BIT
STMMI
ST Microelectronics
BIT
SPM
Saipem
BIT
TRN
Terna Trasmissione Elett...
BIT
TIT
Telecom Italia
BIT
TEN
Tenaris
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network